Expanded Access to ANG1005 for Individual Patients
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Breast Cancer With Recurrent Brain Metastases|Leptomeningeal Carcinomatosis
Interventions: DRUG: ANG1005
Sponsor: Angiochem Inc